| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
GlioblastomaCimetidineGliosarcomaPTENNeoplasia (Tumor biology and immunology)BevacizumabChloroquine| 1 | 2010 | New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab. | 
| + | - | nl | Onco Targets Ther 3(-):27-38 (2010) |
| 2 | 2006 | Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review). |
| + | - | nl | Int J Oncol 28(5):1021-30 (2006) |
| 3 | 2010 | Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. |
| + | - | nl | J Neurosurg 112(5):990-6 (2010) |
| 4 | 2006 | Congenital glioblastoma multiforme. Case report and review of the literature. |
| + | - | nl | J Neurosurg 105(6 Suppl):473-9 (2006) |
| 5 | 2006 | New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy. |
| + | - | nl | Neurosurg Focus 20(4):E6 (2006) |
| 6 | 2006 | Cellular signaling molecules as therapeutic targets in glioblastoma multiforme. |
| + | - | nl | Neurosurg Focus 20(4):E8 (2006) |
| 7 | 2006 | Recurrent glioblastoma multiforme: a review of natural history and management options. |
| + | - | nl | Neurosurg Focus 20(4):E5 (2006) |
| 8 | 2006 | Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme. |
| + | - | nl | Neurosurg Focus 20(4):E4 (2006) |
| 9 | 2006 | Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. |
| + | - | nl | Neurosurg Focus 20(4):E22 (2006) |
| 10 | 2006 | Treatment options for glioblastoma. |
| + | - | nl | Neurosurg Focus 20(4):E19 (2006) |
| 11 | 2006 | Gamma knife surgery for glioblastoma multiforme. |
| + | - | nl | Neurosurg Focus 20(4):E17 (2006) |
| 12 | 2008 | Molecular predictors in glioblastoma: toward personalized therapy. |
| + | - | nl | Arch Neurol 65(7):877-83 (2008) |
| 13 | 1999 | Primary and secondary glioblastomas: from concept to clinical diagnosis. |
| + | - | nl | Neuro Oncol 1(1):44-51 (1999) |
| 14 | 2008 | PTEN signaling pathways in glioblastoma. |
| + | - | nl | Cancer Biol Ther 7(9):1321-5 (2008) |
| 15 | 2009 | Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. | 
| + | - | nl | Cancer Biol Ther 8(19):1791-7 (2009) |
| 16 | 2009 | FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. |
| + | - | nl | Oncologist 14(11):1131-8 (2009) |
| 17 | 2009 | Chloroquine in glioblastoma--new horizons for an old drug. |
| + | - | nl | Cancer 115(11):2380-3 (2009) |
| 18 | 2011 | Treatment advances for glioblastoma. | 
| + | - | nl | Expert Rev Neurother 11(10):1343-5 (2011) |
| 19 | 2008 | Drug cocktails for effective treatment of glioblastoma multiforme. |
| + | - | nl | Expert Rev Neurother 8(4):515-7 (2008) |
| 20 | 2008 | Applications of emerging molecular technologies in glioblastoma multiforme. |
| + | - | nl | Expert Rev Neurother 8(10):1497-506 (2008) |
| 21 | 2007 | Malignant astrocytic glioma: genetics, biology, and paths to treatment. |
| + | - | nl | Genes Dev 21(21):2683-710 (2007) |
